verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: caplin steriles limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler caplin steriles limited
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

verapamil hydrochloride 2.5 mg/mL

Manufacturer
Caplin Steriles Limited

Identifiers & Regulatory

Product NDC 65145-113
Product ID 65145-113_fb2643f1-42d0-410c-a4ab-b0a8ce457cfe
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213232
Listing Expiration 2026-12-31
Marketing Start 2025-01-16

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65145113
Hyphenated Format 65145-113

Supplemental Identifiers

RxCUI
1665057 1665061
UPC
0365145113016 0365145113252 0365145114013
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA213232 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 25 VIAL, SINGLE-DOSE in 1 CARTON (65145-113-25) / 2 mL in 1 VIAL, SINGLE-DOSE (65145-113-01)
source: ndc

Packages (1)

65145-113-25 25 VIAL, SINGLE-DOSE in 1 CARTON (65145-113-25) / 2 mL in 1 VIAL, SINGLE-DOSE (65145-113-01)

Ingredients (1)

verapamil hydrochloride (2.5 mg/mL)

Linked Drug Pages (1)

Verapamil Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "fb2643f1-42d0-410c-a4ab-b0a8ce457cfe", "openfda": {"upc": ["0365145113016", "0365145113252", "0365145114013"], "unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["e18cc04c-a808-4d92-9b66-762cd787abc5"], "manufacturer_name": ["Caplin Steriles Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (65145-113-25)  / 2 mL in 1 VIAL, SINGLE-DOSE (65145-113-01)", "package_ndc": "65145-113-25", "marketing_start_date": "20250116"}], "brand_name": "Verapamil Hydrochloride", "product_id": "65145-113_fb2643f1-42d0-410c-a4ab-b0a8ce457cfe", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "65145-113", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Caplin Steriles Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA213232", "marketing_category": "ANDA", "marketing_start_date": "20250116", "listing_expiration_date": "20261231"}